BRAIN Biotech AG
XETRA:BNN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BRAIN Biotech AG
XETRA:BNN
|
DE |
|
T
|
Tidewater Inc
F:TD9
|
US |
|
Binect AG
XETRA:MA10
|
DE |
|
Nanobiotix SA
PAR:NANO
|
FR |
|
Largo Inc
F:LR8
|
CA |
|
Kokusai Electric Corp
OTC:KOKSF
|
JP |
|
Lamda Development SA
F:LDQ
|
GR |
|
Telkom Indonesia (Persero) Tbk PT
F:PTI
|
ID |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
XBER:GUV
|
HU |
|
A
|
AREIT, Inc
XPHS:AREIT
|
PH |
|
C
|
Cantargia AB
F:7V3
|
SE |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
SWB:GUV
|
HU |
|
F
|
FACC AG
LSE:0QW9
|
AT |
Wall St Price Targets
BNN Price Targets Summary
BRAIN Biotech AG
According to Wall Street analysts, the average 1-year price target for BNN is 5.61 EUR with a low forecast of 5.05 EUR and a high forecast of 6.83 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BNN's stock price target?
Price Target
5.61
EUR
According to Wall Street analysts, the average 1-year price target for BNN is 5.61 EUR with a low forecast of 5.05 EUR and a high forecast of 6.83 EUR.
What is the Revenue forecast for BRAIN Biotech AG?
Projected CAGR
10%
Over the last 12 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for BRAIN Biotech AG?
Projected CAGR
9%
Over the last 12 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 9%.
